Literature DB >> 18544117

Revisiting human primary immunodeficiencies.

Jean-Laurent Casanova1, Claire Fieschi, Shen-Ying Zhang, Laurent Abel.   

Abstract

Human primary immunodeficiencies (PIDs) are often thought to be confined to a few rare, familial, monogenic, recessive traits impairing the development or function of one or several leucocyte subsets and resulting in multiple, recurrent, opportunistic and fatal infections in infancy. We highlight here the rapidly growing number of exceptions to each of these conventional qualifications. Indeed, bona fide PIDs include common and sporadic illnesses and may present as dominant, or even polygenic traits; their pathogenesis may involve non haematopoietic cells, and they may result in single episode of illness, with a single or multiple morbid phenotypes, some of which may involve infection, in otherwise healthy adults. We need to increase awareness of the multitude of clinical presentations of human PIDs considerably and rapidly in the medical community. Human PIDs should be considered in a wide range of clinical situations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544117     DOI: 10.1111/j.1365-2796.2008.01971.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  16 in total

Review 1.  The mucosal firewalls against commensal intestinal microbes.

Authors:  Andrew J Macpherson; Emma Slack; Markus B Geuking; Kathy D McCoy
Journal:  Semin Immunopathol       Date:  2009-08-26       Impact factor: 9.623

2.  Primary immunodeficiency diseases: a 30-year patient registry from the referral center for primary immunodeficiencies in Greece.

Authors:  Athanasios Michos; Maria Raptaki; Sofia Tantou; Marianna Tzanoudaki; Kleopatra Spanou; Manolis Liatsis; Nikki Constantinidou; Evangelia Paschali; Ioanna Varela; Olga Moraloglou; Chryssa Bakoula; Maria Kanariou
Journal:  J Clin Immunol       Date:  2014-07-01       Impact factor: 8.317

3.  Sudden death caused by Staphylococcus aureus carrying Panton-Valentine leukocidin gene in a young girl.

Authors:  Thanh-Van Trieu; Joel Gaudelus; Sophie Lefevre; Anne Marie Teychene; Isabelle Poilane; Anne Colignon; Jerome Etienne; Loïc de Pontual
Journal:  BMJ Case Rep       Date:  2009-11-04

Review 4.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

Review 5.  Primary B-cell immunodeficiencies.

Authors:  Tukisa Smith; Charlotte Cunningham-Rundles
Journal:  Hum Immunol       Date:  2018-10-22       Impact factor: 2.850

6.  Cytokine production assays reveal discriminatory immune defects in adults with recurrent infections and noninfectious inflammation.

Authors:  Jaap Ten Oever; Frank L van de Veerdonk; Leo A B Joosten; Anna Simon; Reinout van Crevel; Bart-Jan Kullberg; Inge C Gyssens; Jos W M van der Meer; Marcel van Deuren; Mihai G Netea
Journal:  Clin Vaccine Immunol       Date:  2014-05-28

Review 7.  Laboratory evaluation of primary immunodeficiencies.

Authors:  João B Oliveira; Thomas A Fleisher
Journal:  J Allergy Clin Immunol       Date:  2009-12-29       Impact factor: 10.793

8.  A digenic human immunodeficiency characterized by IFNAR1 and IFNGR2 mutations.

Authors:  Rodrigo Hoyos-Bachiloglu; Janet Chou; Catherine N Sodroski; Abdallah Beano; Wayne Bainter; Magdalena Angelova; Eman Al Idrissi; Murad K Habazi; Hamza Ali Alghamdi; Fahd Almanjomi; Mohamed Al Shehri; Nagi Elsidig; Morsi Alaa Eldin; David M Knipe; Mofareh AlZahrani; Raif S Geha
Journal:  J Clin Invest       Date:  2017-11-06       Impact factor: 14.808

Review 9.  Toll-like receptor function in primary B cell defects.

Authors:  Thomas U Marron; Joyce E Yu; Charlotte Cunningham-Rundles
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

10.  Suppression of hepcidin expression and iron overload mediate Salmonella susceptibility in ankyrin 1 ENU-induced mutant.

Authors:  Kyoko E Yuki; Megan M Eva; Etienne Richer; Dudley Chung; Marilène Paquet; Mathieu Cellier; François Canonne-Hergaux; Sophie Vaulont; Silvia M Vidal; Danielle Malo
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.